397 related articles for article (PubMed ID: 16738314)
1. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells.
Ohgushi M; Kuroki S; Fukamachi H; O'Reilly LA; Kuida K; Strasser A; Yonehara S
Mol Cell Biol; 2005 Nov; 25(22):10017-28. PubMed ID: 16260615
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 inhibits cell proliferation and induces apoptosis by TGF-beta-dependent and -independent mechanisms in human colon carcinoma cells.
Tong DD; Jiang Y; Li M; Kong D; Meng XN; Zhao YZ; Jin Y; Bai J; Fu SB; Geng JS
Pathobiology; 2009; 76(4):163-9. PubMed ID: 19571605
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.
Yamamura Y; Lee WL; Inoue K; Ida H; Ito Y
J Biol Chem; 2006 Feb; 281(8):5267-76. PubMed ID: 16373335
[TBL] [Abstract][Full Text] [Related]
7. How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions.
Vogiatzi P; De Falco G; Claudio PP; Giordano A
Cancer Biol Ther; 2006 Apr; 5(4):371-4. PubMed ID: 16627973
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and post-translational regulation of Bim is essential for TGF-β and TNF-α-induced apoptosis of gastric cancer cell.
Ha Thi HT; Lim HS; Kim J; Kim YM; Kim HY; Hong S
Biochim Biophys Acta; 2013 Jun; 1830(6):3584-92. PubMed ID: 23500081
[TBL] [Abstract][Full Text] [Related]
10. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
11. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
13. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
[TBL] [Abstract][Full Text] [Related]
14. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
15. Causal relationship between the loss of RUNX3 expression and gastric cancer.
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
17. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
[TBL] [Abstract][Full Text] [Related]
18. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
[TBL] [Abstract][Full Text] [Related]
19. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
Nakanishi Y; Shiraha H; Nishina S; Tanaka S; Matsubara M; Horiguchi S; Iwamuro M; Takaoka N; Uemura M; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
BMC Cancer; 2011 Jan; 11():3. PubMed ID: 21205319
[TBL] [Abstract][Full Text] [Related]
20. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
Lin FC; Liu YP; Lai CH; Shan YS; Cheng HC; Hsu PI; Lee CH; Lee YC; Wang HY; Wang CH; Cheng JQ; Hsiao M; Lu PJ
Oncogene; 2012 Sep; 31(39):4302-16. PubMed ID: 22231444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
